Ocrevus (Ocrelizumab) is used for the treatment of patients with multiple sclerosis.

OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.

Ocrevus (Ocrelizumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Ocrevus (Ocrelizumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the OCREVUS (ocrelizumab) injection medicine cost price in India.

The order for Ocrevus (Ocrelizumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Ocrelizumab (trade name Ocrevus) is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It was approved by the FDA in March 2017 as a treatment for multiple sclerosis, and the first FDA approved drug for the primary progressive form of MS;

OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017

Generic Name: Ocrelizumab

Injection: 300 mg/10 mL (30 mg/mL) in a single-dose vial.

Ocrevus (ocrelizumab)

OCREVUS (ocrelizumab) injection is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | MUMBAI | BENGALURU | KOLKATA | LUCKNOW | JAIPUR | JODHPUR | PUNJAB | CHANDIGARH
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Ocrevus (Ocrelizumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Ocrevus (Ocrelizumab) on prescription and Import License in Patient's Name only.

For overseas patients, Ocrevus (Ocrelizumab) can be made available in Send your enquiry to find Ocrevus (Ocrelizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Ocrevus (Ocrelizumab).

MS Treatment Cheat Sheet For More Details

Biogen scores FDA nod for Tecfidera follow-up Vumerity as MS threats linger For More Details

Get Access To FDA Approved Drug OCREVUS (ocrelizumab) injection In india

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in multiple sclerosis-MS (relapsing or primary progressive forms) treatment. Brand Name "OCREVUS (ocrelizumab) injection" or Generic Name "Ocrelizumab injection" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.